Operating Lease, Right-of-Use Asset of Krystal Biotech, Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Krystal Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Krystal Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $7,447,000, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Krystal Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,447,000 +$976,000 +15% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $7,655,000 +$995,000 +15% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $7,858,000 +$1,013,000 +15% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $6,280,000 -$747,000 -11% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $6,471,000 -$889,000 -12% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $6,660,000 -$930,000 -12% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 $6,845,000 -$969,000 -12% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $7,027,000 -$1,015,000 -13% 31 Dec 2023 10-K 19 Feb 2025 2024 FY
Q3 2023 $7,360,000 -$893,000 -11% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $7,590,000 -$689,000 -8.3% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q1
Q1 2023 $7,814,000 -$639,000 -7.6% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $8,042,000 +$814,000 +11% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 $8,253,000 +$911,000 +12% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $8,279,000 +$1,143,000 +16% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $8,453,000 +$5,253,000 +164% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $7,228,000 +$3,930,000 +119% 31 Dec 2021 10-K 27 Feb 2023 2021 FY
Q3 2021 $7,342,000 +$4,866,000 +197% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $7,136,000 +$4,581,000 +179% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,200,000 -$98,000 -3% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $3,298,000 +$589,000 +22% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $2,476,000 -$320,000 -11% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $2,555,000 -$351,000 -12% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $3,298,000 +$297,000 +9.9% 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $2,709,000 +$1,609,000 +146% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $2,796,000 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $2,906,000 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $3,001,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $1,100,000 01 Jan 2019 10-Q 09 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.